More on TNXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+32.3% Growth)
- Ratings (6.0 Score)
- Holders

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tonix Pharma (NQ:TNXP)
Delayed: 5.17 +0.04 (0.78%)
Prev. Close $5.13  
Open$5.09 
52 Wk High$7.95 
52 Wk Low$0.40 
Day High$5.20 
Day Low$5.01 
P/E N/A  
EPS$-5.33 
Volume754,341 

Friends, Peers and Foes (?): AEMD, CVKD, DYAI, ICU, JAGX (more...)

Oct 20, 2026 06:35 AM Tonix Pharma (TNXP) PT Lowered to $26 at Raymond James
Oct 19, 2026 07:01 AM Tonix to present TONMYA phase 3 data at pain congress
Oct 19, 2026 07:00 AM Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
Oct 15, 2026 07:00 AM Form 8-K Tonix Pharmaceuticals For: Oct 15
Oct 15, 2026 07:00 AM Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Oct 2, 2026 05:20 PM Form 8-K Tonix Pharmaceuticals For: Oct 01
Sep 22, 2026 07:06 AM Form 8-K Tonix Pharmaceuticals For: Sep 22
Sep 22, 2026 07:03 AM Tonix adds second Medicare payer deal for fibromyalgia drug Tonmya
Sep 22, 2026 07:00 AM Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Sep 22, 2026 05:06 AM Raymond James Reiterates Strong Buy Rating on Tonix Pharma (TNXP)
View All Articles

Entities mentioned with TNXP

View All Entities